The latest price target for Kindly MD (NASDAQ:NAKA) was reported by B. Riley Securities on November 20, 2025. The analyst firm set a price target for $1.00 expecting NAKA to rise to within 12 months (a possible 143.55% upside). 3 analyst firms have reported ratings in the last year.

The latest analyst rating for Kindly MD (NASDAQ:NAKA) was provided by B. Riley Securities, and Kindly MD maintained their buy rating.

There is no last upgrade for Kindly MD

There is no last downgrade for Kindly MD.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Kindly MD, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Kindly MD was filed on November 20, 2025 so you should expect the next rating to be made available sometime around November 20, 2026.

While ratings are subjective and will change, the latest Kindly MD (NAKA) rating was a maintained with a price target of $2.00 to $1.00. The current price Kindly MD (NAKA) is trading at is $0.41, which is out of the analyst’s predicted range.